Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|January 9, 2016
Global Consensus Recommendations on Prevention and Management of Nutritional RicketsCraig F Munns, Nick Shaw, Mairead Kiely, et al.Lancet (London, England)|April 9, 2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsAntoinette Moran, Brian Bundy, Dorothy J Becker, et al.Diabetes Care|November 23, 2019
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 DiabetesManuela Battaglia, Simi Ahmed, Mark S Anderson, et al.Journal of Women'S Health (2002)|August 18, 2025
Engaging Peer Mentors for Opportunity, Well-Being, and Equity Realization-A Leadership Intervention for Women in Academic MedicineChristina M Cutter, Rochelle D Jones, Nancy D Spector, et al.Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.Diabetes|January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 DiabetesCarla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.JCI Insight|November 8, 2021
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetesCarla J Greenbaum, Elisavet Serti, Katharina Lambert, et al.Diabetes Care|November 12, 2025
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 DiabetesMichael J Haller, Lauren Kanapka, Roshanak Monzavi, et al.HIV Medicine|December 6, 2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected childrenT I Miller, W Borkowsky, L A DiMeglio, et al.Diabetes Care|June 24, 2024
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 DiabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.Pageof 24